Welcome to our dedicated page for Honeywell Intl SEC filings (Ticker: HON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Honeywell International Inc. (NASDAQ: HON), including current reports on Form 8-K and other key documents. These filings offer detailed information on Honeywell’s segment structure, portfolio actions, financing arrangements, governance changes and material events.
Honeywell’s recent 8-K filings describe several significant corporate developments. The company has reported on the completed spin-off of its Advanced Materials business into Solstice Advanced Materials Inc., which now trades separately on Nasdaq under the ticker SOLS, and on the planned separation of its global Aerospace Technologies business into an independent, publicly traded company. Other filings outline the realignment of Honeywell’s reportable segments into Aerospace Technologies, Building Automation, Process Automation and Technology, and Industrial Automation, with additional operations in Corporate and All Other.
Filings also detail capital markets activity and liability management. Honeywell lists multiple series of senior notes on Nasdaq, and its 8-Ks identify these securities and their terms. The company has disclosed the permanent divestiture of certain legacy asbestos liabilities through the sale of a subsidiary holding those liabilities and related insurance assets, and has described an agreement with Resideo Intermediate Holding Inc. to terminate an indemnification and reimbursement arrangement via a one-time cash payment, subject to closing conditions.
Through Stock Titan, users can monitor new Honeywell filings as they are posted to EDGAR and use AI-powered summaries to interpret complex documents such as Form 8-Ks, 10-K annual reports, 10-Q quarterly reports and proxy materials. The filings page is a central resource for understanding Honeywell’s regulatory disclosures, including segment realignments, spin-offs, leadership changes and significant agreements affecting HON shareholders and bondholders.
Lucian Boldea, President and CEO, IA of Honeywell International Inc. (HON), reported multiple stock option exercises and open-market sales on 08/27/2025. He exercised 17,594 options at $171.73, 11,903 options at $199.60, and 6,684 options at $197.68 to acquire the same number of common shares. On the same date he sold matching amounts: 17,594 shares at a weighted-average price of $221.6036, 11,903 shares at $221.6036, 6,684 shares at $221.6036, and an additional 5,968 shares at $221.4404. Following these transactions, the reporting person beneficially owned 16,302 shares directly, with an additional 259.1954 indicated as held indirectly in a 401(k) plan.
The Form 4 lists the exercised options' original grant details and vesting schedules and discloses that the reported sale prices were executed in multiple transactions (range noted in footnote). These are routine officer option exercises and subsequent share sales reported under Section 16.
Form 144 filed for Honeywell International (HON) discloses a proposed sale of 5,968 shares of common stock through J.P. Morgan Securities LLC with an aggregate market value of $1,328,238. The filing names NASDAQ as the exchange and indicates an approximate sale date of 08/27/2025. The shares were acquired via multiple RSU vest events on dates including 10/17/2022, 10/03/2023, 12/04/2023, 03/18/2024 and 06/10/2024. The filer certifies no undisclosed material information and states there were no sales in the past three months by the reporting person.
Honeywell International (HON) filed a Form 144 notifying the proposed sale of 36,181 common shares to be executed through Morgan Stanley Smith Barney on the Nasdaq on 08/27/2025. The filing shows an aggregate market value of $8,017,839.85 and total shares outstanding listed as 634,896,562. The securities reported were acquired on 08/27/2025 through the exercise of options under a registered plan, in three tranches of 17,594, 6,684, and 11,903 shares, each paid in cash on the acquisition date. The filer states there were no sales by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Honeywell named Peter Lau as President and CEO of its Industrial Automation segment, effective October 15, 2025. Mr. Lau, age 46, will report to Chairman and CEO Vimal Kapur. The current IA leader, Lucian Boldea, age 54, will depart the company on August 31, 2025. Mr. Lau served as President and CEO of FARO Technologies from July 2023 until October 2025 and previously led Honeywell's Security, Fire and Electrical Products businesses from January 2018 to August 2020. He has also held senior roles at Hubbell, General Electric and Catalyst Nutraceuticals and holds a B.S. in Business Administration from Northeastern University.
Honeywell International announced on August 21, 2025 that Solstice Advanced Materials, LLC, a wholly owned Honeywell subsidiary, filed a Form 10 with the SEC to convert into a Delaware corporation and be renamed Solstice Advanced Materials Inc. The Form 10 filing was made in connection with the anticipated spin-off of Honeywell's Advanced Materials business into an independent, publicly traded company. Honeywell furnished press releases as Exhibits 99.1 and 99.2: one announcing the Form 10 filing and the other disclosing the anticipated post-spin-off board composition for Solstice. The report states the furnished information is not "filed" under the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Honeywell International (HON) Form 144 filing discloses a planned sale of 3,448 common shares through Morgan Stanley Smith Barney on or about 01 Aug 2025. Based on the filer’s reference price, the transaction is valued at $752,026. The shares originate from recent restricted-stock vesting and option exercises under Honeywell’s equity-compensation plans. With 634.9 million shares outstanding, the proposed sale equals roughly 0.0005 % of total shares.
No sales have been reported in the past three months, and the signer certifies possession of no undisclosed adverse information, as required by Rule 144. Because Form 144 only signals intent, the sale may or may not be executed. Given the modest size relative to Honeywell’s float and average trading volumes, the filing appears to be routine insider activity with limited market impact.